Keywords: لنفوم هاجکین; Hodgkin lymphoma; Bone marrow biopsy; Middle East and North Africa; Positron emission tomography;
مقالات ISI لنفوم هاجکین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لنفوم هاجکین; Early; Focal; Hodgkin lymphoma; Interfollicular;
Keywords: لنفوم هاجکین; Inflammatory bowel disease; Hodgkin lymphoma; Gastrointestinal;
Keywords: لنفوم هاجکین; HL; Hodgkin lymphoma; NHL; Non-Hodgkin lymphoma; PEDS; Patient Epidemiology Data System; OR; odds ratio; CI; confidence interval; Hodgkin lymphoma risk; Non-Hodgkin lymphoma risk; Physical inactivity;
Keywords: لنفوم هاجکین; Brentuximab vedotin; Hodgkin lymphoma; Pulmonary infiltration;
Keywords: لنفوم هاجکین; ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; APL; acute promyelocytic leukaemia; ASR; age standardised incidence rates; CI; confidence interval; CML; chronic myeloid leukaemia; ECP; Eastern Cape Province; HMs; haematological malignanc
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Renal involvement; Acute kidney injury; Chemotherapy;
Keywords: لنفوم هاجکین; ADC; apparent diffusion coefficient; BMB; bone marrow biopsy; DLBCL; diffuse large B-cell lymphoma; DWI; diffusion-weighted imaging; HL; Hodgkin lymphoma; SUV; standardized uptake value; VOI; volume of interest; WB-DWI; whole-body diffusion-weighted imagi
Keywords: لنفوم هاجکین; Primary immunodeficiency; Hematologic malignancy; Lymphoma; Leukemia; Hodgkin; AD; Autosomal dominant; ADA; Adenosine deaminase; AML; Acute myeloid leukemia; AR; Autosomal recessive; CID; combined immunodeficiency; HL; Hodgkin lymphoma; HLH; Hemophagocyti
Keywords: لنفوم هاجکین; HL; Hodgkin lymphoma; ER; estrogen receptor; PR; progesterone receptor; ECOG; Eastern Cooperative Oncology Group; Hodgkin lymphoma survivors; Secondary breast cancer; Breast cancer chemotherapy; Chemotherapy tolerability;
Keywords: لنفوم هاجکین; Complete remission; Hodgkin lymphoma; Period analysis; Survival pattern; Three decades;
Keywords: لنفوم هاجکین; Auto-SCT in Hodgkin lymphoma; Hodgkin lymphoma; Refractory Hodgkin lymphoma; Relapsed Hodgkin lymphoma; Targeted agents in Hodgkin lymphoma;
Keywords: لنفوم هاجکین; TNFAIP3; A20; Hodgkin lymphoma; Mutation analysis; NF-κB signaling;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; novel agents; PET-CT scanning;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; lymphoma; lymphoma frequency; non-Hodgkin lymphoma; Taiwan;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Autologous stem cell transplantation; Absolute lymphocyte count; Absolute monocyte count; Prognostic;
Keywords: لنفوم هاجکین; Veterans; Military; Leukaemia; Hodgkin lymphoma; Non-Hodgkin lymphoma; Retrospective cohort study;
Keywords: لنفوم هاجکین; Irradiation induced coronary artery disease; Computed tomography angiography; Hodgkin lymphoma;
Keywords: لنفوم هاجکین; EBV; Epstein-Barr virus; HPV; human papilloma virus; HCV; hepatitis C virus; LMP1; latent membrane protein 1; NPC; nasopharyngeal carcinoma; BL; Burkitt's lymphoma; HL; Hodgkin lymphoma; HIF-1α; hypoxia-inducible factor-1α; TNFR; tumor necrosis factor
Keywords: لنفوم هاجکین; Hodgkin lymphoma; prevalence; relapsed or refractory Hodgkin lymphoma;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; mitochondria; oxidative phosphorylation; glycolysis; lactate; ketone bodies;
Keywords: لنفوم هاجکین; Retrospective dosimetry; Hodgkin lymphoma; Breast carcinogenesis;
Keywords: لنفوم هاجکین; Chemotherapy; Hodgkin lymphoma; practice guidelines; radiation therapy; systematic review;
Keywords: لنفوم هاجکین; Allogeneic; Autologous; Hematopoietic cell transplantation; Immunotherapies; Hodgkin lymphoma; Relapse;
Keywords: لنفوم هاجکین; ADCC; antibody dependent cellular cytotoxicity; AML; acute myeloid leukemia; CMV; cytomegalovirus; CR; complete remission; HL; Hodgkin lymphoma; HLA; human leukocyte antigen; HLH; hemophagocytic lymphohistiocytosis; KIR; killer cell inhibitory immunoglobu
Keywords: لنفوم هاجکین; Anti-programmed death 1; Hodgkin lymphoma;
Keywords: لنفوم هاجکین; Cancer; Rehabilitation; Radiation fibrosis syndrome; Late effects; Hodgkin lymphoma; Head and neck cancer; Neuromuscular; Musculoskeletal;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Non-Hodgkin lymphoma; Radiotherapy; Breast dose reduction; Heart dose reduction; Inclined board;
Keywords: لنفوم هاجکین; Epstein barr virus; EBV; Hemophagocytic lymphohistiocytosis; Anti-CD 20; Rituximab; Hodgkin lymphoma; Richter's;
Keywords: لنفوم هاجکین; Epstein–Barr Virus; Hodgkin lymphoma; LMP1 immunohistochemistry; Real-time PCR; Viral load
Keywords: لنفوم هاجکین; Chemotherapy; Hepatic dysfunction; Hodgkin lymphoma; Liver failure; Review;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Early stage; ABVD; Positron emission tomography (PET); Interim PET
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Relapse; High-dose chemotherapy; Autologous stem cell transplant; Brentuximab vedotin
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Presentation; Staging; PET
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Late effects; Second malignant neoplasms; Cardiovascular disease
Keywords: لنفوم هاجکین; Epstein-Barr virus; Hodgkin lymphoma; Burkitt lymphoma; Diffuse large B-cell lymphoma; Pediatric lymphoma; Virus de Epstein-Barr; Linfoma de Hodgkin; Linfoma de Burkitt; Linfoma difuso de células B; Linfoma pediátrico;
Keywords: لنفوم هاجکین; IMRT; Hodgkin lymphoma; Survival; NCDB
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Paediatric; Prognostic factor;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Birth weight; Birth order; Paediatric cancer; Case-control study;
Keywords: لنفوم هاجکین; Germinal center; Hodgkin lymphoma; LP cell
Keywords: لنفوم هاجکین; Richter transformation; Chronic lymphocytic leukemia; Hodgkin lymphoma; Epstein-Barr virus; Clonality; ZAP-70; Reed-Sternberg cell;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Lymphomas; Central and South America; Incidence; Mortality;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Prognostic factors; Biology; Relapsed/refractory; Positron emission tomography
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Tumor microenvironment; Immune-escape; Angiogenesis; Drug-resistance;
Keywords: لنفوم هاجکین; Lymphome d'Hodgkin; Lymphome B diffus à grandes cellules; Lymphome primitif du médiastin; Hodgkin lymphoma; Diffuse large B-cell lymphoma; Primary mediastinal lymphoma;
Keywords: لنفوم هاجکین; Lymphoma; Cutaneous T-cell lymphoma; Cutaneous B-cell lymphoma; Paraneoplastic phenomena; Anaplastic large cell lymphoma; Hodgkin lymphoma;
Keywords: لنفوم هاجکین; Hodgkin lymphoma; Stent; Superior vena cava syndrome
Keywords: لنفوم هاجکین; Cardiovascular disease; Hodgkin lymphoma; Mortality; Race; SEER
Keywords: لنفوم هاجکین; Autologous hematopoietic transplantation; Salvage; Hodgkin lymphoma; Brentuximab vedotin
Keywords: لنفوم هاجکین; LMCA; left main coronary artery; LADCA; left anterior descending coronary artery; LCCA; left circumflex coronary artery; RCA; right coronary artery; CCA; common carotid artery; ECA; external carotid artery; ICA; internal carotid artery; parotid; parotid g